Twitter

Archive for August, 2012


Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

Condition :   Untreated Stage III Melanoma or Stage IV Melanoma Interventions :   Biological: Ipilimumab;   Drug: Carboplatin;   Drug: Paclitaxel Sponsors :   Jewish General Hospital;   Jewish General Hospital Not yet recruiting – verified August 2012

Read More...

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

Conditions :   Malignant Melanoma Stage III;   Malignant Melanoma Stage IV Intervention :   Biological: Dendritic cell therapy Sponsors :   Universitair Ziekenhuis Brussel;   Universitair Ziekenhuis Brussel;   RIZIV Not yet recruiting – verified August 2012

Read More...

A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Condition :   Relapsed or Refractory Diffuse Large B Cell Lymphoma Intervention :   Drug: 131I-rituximab Sponsors :   Korea Cancer Center Hospital;   Korea Cancer Center Hospital Active, not recruiting – verified August 2012

Read More...

Phase I/Ib Dose-escalation of Dinaciclib With Weekly Paclitaxel for Advanced Solid Tumor Malignancies & Assessment of MYC Oncogene Overexpression

Conditions :   Malignant Solid Tumour;   Triple-negative Breast Cancer Intervention :   Drug: Dinaciclib & paclitaxel treatment Sponsors :   University of California, San Francisco;   Jo Chien;   Merck Recruiting – verified August 2012

Read More...

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Conditions :   Refractory Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma;   Thrombocytopenia Intervention :   Biological: romiplostim Sponsors :   New York University School of Medicine;   New York University School of Medicine;   National Cancer Institute (NCI) Recruiting – verified August 2012

Read More...

An Observational Study of Avastin and Conventional Chemotherapy in Patients >/= 70 Years of Age With Previously Untreated Metastatic Colorectal Cancer (AVAPLUS)

Condition :   Colorectal Cancer Intervention :   Sponsors :   Hoffmann-La Roche;   Hoffmann-La Roche Recruiting – verified August 2012

Read More...

Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"

Condition :   Dietary Carcinogenesis Interventions :   Drug: ACCS100;   Drug: Placebo Sponsors :   Texas Enterosorbents Incorporated;   Texas Enterosorbents Incorporated;   Texas A&M University;   University of Georgia;   University of Texas Recruiting – verified August 2012

Read More...

Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer

Conditions :   Non-Small Cell Lung Cancer;   Colorectal Cancer Intervention :   Drug: Dovitinib Sponsors :   University of California, Davis;   University of California, Davis;   Novartis Not yet recruiting – verified August 2012

Read More...

SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma

Conditions :   Vulvar Intraepithelial Neoplasia;   Genital Warts Interventions :   Drug: SR-T100 gel with 2.3% of SM in Solanum Undatum plant extract;   Drug: SR-T100 gel with 2.3% of SM in Solanum undatum plant extract Sponsors :   National Cheng-Kung University Hospital;   National Cheng-Kung University Hospital;   G&E Herbal Biotechnology Co., LTD Recruiting – verified August 2012

Read More...

Lymphoid Malignancies and Precursors: Tissue Acquisition Protocol

Conditions :   Hodgkin Disease;   Lymphoma, Non-Hodgkin;   Multiple Myeloma;   Lymphomatoid Granulomatosis;   Leukemia-Lymphoma, Adult T-Cell Intervention :   Sponsors :   National Institutes of Health Clinical Center (CC);   National Cancer Institute (NCI) Recruiting – verified August 2012

Read More...